Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 28% ± 6% | |
brain | 12 studies | 26% ± 8% | |
lung | 10 studies | 32% ± 14% | |
intestine | 8 studies | 28% ± 13% | |
kidney | 7 studies | 27% ± 10% | |
eye | 5 studies | 30% ± 10% | |
lymph node | 4 studies | 26% ± 5% | |
pancreas | 3 studies | 45% ± 5% | |
placenta | 3 studies | 27% ± 13% | |
bone marrow | 3 studies | 19% ± 4% | |
adrenal gland | 3 studies | 21% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 29078.76 | 258 / 258 | 100% | 195.53 | 230 / 230 |
esophagus | 100% | 16854.79 | 1445 / 1445 | 100% | 103.75 | 183 / 183 |
ovary | 100% | 18949.81 | 180 / 180 | 100% | 123.26 | 430 / 430 |
thymus | 100% | 14082.44 | 653 / 653 | 100% | 163.96 | 605 / 605 |
skin | 100% | 15048.05 | 1808 / 1809 | 100% | 144.36 | 472 / 472 |
brain | 100% | 21141.64 | 2640 / 2642 | 100% | 160.20 | 705 / 705 |
uterus | 100% | 15650.68 | 170 / 170 | 100% | 149.85 | 458 / 459 |
kidney | 100% | 15492.07 | 89 / 89 | 100% | 124.17 | 899 / 901 |
stomach | 100% | 10300.27 | 359 / 359 | 100% | 124.98 | 285 / 286 |
breast | 100% | 13259.28 | 459 / 459 | 100% | 146.99 | 1114 / 1118 |
intestine | 100% | 14018.82 | 966 / 966 | 100% | 141.95 | 525 / 527 |
bladder | 100% | 15360.48 | 21 / 21 | 99% | 148.25 | 501 / 504 |
prostate | 100% | 14424.31 | 245 / 245 | 99% | 167.87 | 499 / 502 |
liver | 100% | 5553.67 | 225 / 226 | 100% | 79.73 | 404 / 406 |
lung | 100% | 11408.96 | 576 / 578 | 99% | 111.37 | 1147 / 1155 |
pancreas | 97% | 6313.25 | 319 / 328 | 100% | 121.95 | 178 / 178 |
adipose | 100% | 12539.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 181.38 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 158.66 | 29 / 29 |
muscle | 100% | 17837.97 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 10498.90 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 123.32 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 90.54 | 1 / 1 |
blood vessel | 100% | 14949.57 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 20874.58 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 8782.26 | 857 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043029 | Biological process | T cell homeostasis |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0007059 | Biological process | chromosome segregation |
GO_0007143 | Biological process | female meiotic nuclear division |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0051754 | Biological process | meiotic sister chromatid cohesion, centromeric |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0035331 | Biological process | negative regulation of hippo signaling |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0045595 | Biological process | regulation of cell differentiation |
GO_0051232 | Biological process | meiotic spindle elongation |
GO_2001241 | Biological process | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO_0051306 | Biological process | mitotic sister chromatid separation |
GO_1903538 | Biological process | regulation of meiotic cell cycle process involved in oocyte maturation |
GO_0040008 | Biological process | regulation of growth |
GO_0000775 | Cellular component | chromosome, centromeric region |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0090443 | Cellular component | FAR/SIN/STRIPAK complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0043025 | Cellular component | neuronal cell body |
GO_0043005 | Cellular component | neuron projection |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0000159 | Cellular component | protein phosphatase type 2A complex |
GO_0005634 | Cellular component | nucleus |
GO_1990405 | Molecular function | protein antigen binding |
GO_0004722 | Molecular function | protein serine/threonine phosphatase activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0019888 | Molecular function | protein phosphatase regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PPP2R1A |
Protein name | Protein phosphatase 2 scaffold subunit Aalpha (cDNA FLJ33169 fis, clone ADRGL2000384, highly similar to Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform) Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha) Protein phosphatase 2 scaffold subunit Aalpha Protein phosphatase 2 (Formerly 2A), regulatory subunit A (PR 65), alpha isoform (Testicular secretory protein Li 1) (cDNA, FLJ96799, Homo sapiens protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform (PPP2R1A), mRNA) |
Synonyms | hCG_19686 |
Description | FUNCTION: The PR65 subunit of protein phosphatase 2A serves as a scaffolding molecule to coordinate the assembly of the catalytic subunit and a variable regulatory B subunit. Upon interaction with GNA12 promotes dephosphorylation of microtubule associated protein TAU/MAPT . Required for proper chromosome segregation and for centromeric localization of SGO1 in mitosis . Together with RACK1 adapter, mediates dephosphorylation of AKT1 at 'Ser-473', preventing AKT1 activation and AKT-mTOR signaling pathway (By similarity). Dephosphorylation of AKT1 is essential for regulatory T-cells (Treg) homeostasis and stability (By similarity). . |
Accessions | ENST00000477989.1 M0QXG4 A0A994J3N8 ENST00000703398.1 P30153 ENST00000322088.11 E9PH38 ENST00000391791.4 ENST00000703422.1 C9J9C1 B3KQV6 ENST00000490868.5 ENST00000703401.1 A8K7B7 ENST00000703423.1 A0A994J3H1 ENST00000454220.7 ENST00000703395.1 A0A994J6A3 M0R0K6 ENST00000462990.5 ENST00000703397.1 |